Entrepreneur's Roundtable - February 25, 2014
Tuesday, February 25, 2014 from 12:00 PM to 1:00 PM (EST)
San Francisco, California
London, United Kingdom
Dr. G. Thomas Caltagirone is the president and CEO of Aptagen and has over 20 years of research and business experience in start-ups. A native of York, Pennsylvania, he began his studies at the University of the Sciences in Philadelphia followed by a Ph.D. in neuroscience from Drexel University. He completed his thesis on "Proton-Sensitive Ribozyme Switches with Molecular Memory" at Yale University.
Aptagen, LLC is a biotechnology company offering aptamer (synthetic antibody) products and services as research reagents, diagnostics and biomarker discovery tools, as well as for use in drug discovery and targeted delivery for therapeutics and bioindustrial applications.
Aptagen has grown from a one-man operation with the help of local interns to a tight-knit developing business with clients ranging globally from research academics at top-tier institutions to big pharma companies. Aptagen has been named as a finalist for the "Top Emerging Business of the Year" by Central Penn Business Journal. Apatmers are an emerging technology that is poised to become the next evolution in diagnostic and drug discovery. Apatgen continues to play a leading role in developing aptamer technology that will assist in the treatment and diganosis of various diseases.
Aptagen was formed in 2004. Operations began in 2006. Aptagen is located in Jacobus, Pennsylvania, a suburb of York, beautifully surrounded by Lake Redman and conveniently situated off Interstate 83. The facility is a fort minute drive from Johns Hopkins University and Penn State Hershey.